Atlassian 3Q26: Cloud Revenue Accelerates on AI Monetization, Maintain Overweight

Core Conclusion

Atlassian's Q3 FY26 results demonstrate a structural inflection in cloud revenue growth, accelerating to 29% YoY (from 26% last quarter) and exceeding consensus by 4.5%—the largest beat in four years. AI monetization via Teamwork Collections and Rovo is driving paid seat expansion and usage intensity, while non-GAAP operating margins reached 34%, +600bps above consensus, fueled by restructuring benefits and cloud infrastructure optimization. Despite a 60% YTD stock decline, the company is proving 20%+ top-line durability and expanding operating leverage. At 10x CY27e free cash flow, shares offer substantial upside. We maintain Overweight with a $120 price target, implying 74% upside from $68.59.

What the Market May Be Underestimating

The dominant bear case—that AI-driven developer productivity gains will reduce headcount and shrink Atlassian's addressable market—rests on a narrow view of the business. Three critical misconceptions exist:

1. AI as a seat expansion catalyst, not a contraction risk. Teamwork Collections customers (primary AI monetization vehicle) expand seat counts >10% and consume 2x AI credits per paid user and 2x active agents versus standalone customers. Rovo has reached "millions" of monthly active users, with AI credit usage growing >20% month-over-month. AI agents become more effective and token-efficient through Atlassian's Teamwork Graph, creating a virtuous cycle that drives deeper penetration into customer organizations.

2. Business diversification beyond developers. Service Collection ARR exceeded $1B, growing >30% YoY, with enterprise ARR exceeding 50% growth. Critically, >60% of instances support non-IT functions (HR, legal, finance, marketing, customer service). Competitive displacement from a major ITSM provider was the largest ever in a single quarter.

3. Structural margin improvement is sustainable. The 8% workforce reduction and cloud infrastructure optimization are delivering operating margin leverage that will persist. Q3 non-GAAP operating margin of 34% was up >800bps YoY, and Q4 guidance of 30.5% implies continued expansion versus consensus of 25%.

Evidence Chain

Claim 1: Cloud revenue acceleration is driven by paid seat expansion and cross-sell, not pricing or one-time events.

• Q3 cloud revenue +29% YoY vs +26% in Q2, with implied Q4 guidance midpoint of 25.5% (raised >2% from prior).
• Net retention rate above 120%, indicating existing customers are expanding faster than churn.
• RPO reached $4.0B, up 37% YoY, reflecting larger and longer commitments.

Claim 2: AI monetization is tangible and accelerating.

• Teamwork Collections customers show >10% seat expansion post-implementation.
• Rovo users contribute ~2x ARR growth rate versus non-Rovo customers.
• Enterprise customers running more workflows across multiple collections, consistent with node expansion thesis.

Claim 3: Margin expansion is structural and beats conservative guidance.

• Non-GAAP operating margin 34% in Q3, consensus at 28%. Q4 guide 30.5% vs consensus 25%.
• Gross margin improvement driven by cloud infrastructure optimization.
• Operating expense leverage from restructuring (8% workforce reduction) is permanent.

Claim 4: Business mix is broadening beyond IT.

• Service Collection >$1B ARR, growing >30% YoY, enterprise ARR >50%.

• 60% of instances support HR, legal, finance, marketing, customer service.

• Competitive displacement largest ever from a major ITSM provider.

Data Center note: Q3 Data Center revenue grew 44% YoY, 9% above consensus, but ~$50M was upfront recognition of pulled-forward term deals. Expect meaningful deceleration in FY27 as this timing benefit unwinds.

Key Disagreements & Risks

1. Data Center revenue sustainability. The 44% YoY growth included ~$50M one-time upfront revenue recognition from pulled-forward term deals. Management acknowledged lumpy timing and expects FY27 deceleration. If underlying demand is weaker than assumed, total revenue growth could undershoot.

2. Large customer acquisition slowing. >$10K cloud ARR customer net adds dropped to 544 from 1,266 a year ago. This could signal saturation in the SMB/B segment or go-to-market disruption from the restructuring. If enterprise traction does not re-accelerate, growth may slow.

3. Free cash flow pressure from restructuring. FCF declined 12% YoY in Q3 due to severance payments, with additional costs in Q4. While temporary, it masks underlying cash generation quality. If restructuring benefits do not fully materialize, FCF recovery may lag.

4. Macro and geopolitical uncertainty. Management described guidance as "prudent" given uncertainty. If enterprise purchasing behavior weakens or sales cycle elongation persists, the optimistic cloud growth trajectory could face headwinds.

5. AI competitive displacement risk. While Atlassian is winning from a major ITSM provider, AI-native alternatives (e.g., from startups or hyperscalers) could emerge faster than expected, pressuring pricing or seat count.

Valuation or Trading Implications

At $68.59, TEAM trades at 10x CY27e FCF, a significant discount to both historical multiples and SaaS peers growing at similar rates. Our $120 price target is derived from a 15x EV/CY27e FCF multiple (0.45x growth-adjusted, at 0.33x on base case), implying 74% upside.

The key catalysts: (1) Next week's Analyst Day, where management is expected to provide enhanced disclosures on Data Center ARR and the durability of cloud growth drivers; (2) Sustained evidence of AI-driven seat expansion and margin leverage; (3) Potential guidance reset toward more conservative but achievable levels.

Risk-reward: Bull case $180 (19x CY27e FCF) assumes material share gains in team productivity market; base case $120; bear case $42 (5.6x CY27e FCF) assumes saturation and disappointing non-IT traction. Options market implies ~36% probability of bear case, which we view as overly punitive given the improving operational trajectory.

Recommendation: Maintain Overweight. The combination of accelerating cloud revenue, expanding margins, and a depressed valuation provides a compelling risk-reward for patient investors.

Appendix: Key Financial Drivers (Morgan Stanley Estimates)